- Home
- LIXT vs ANGH Comparison
LIXT vs ANGH Comparison
Compare LIXT & ANGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIXT
- ANGH
- Stock Information
- Founded
- LIXT 2005
- ANGH 2012
- Country
- LIXT United States
- ANGH United Arab Emirates
- Employees
- LIXT N/A
- ANGH N/A
- Industry
- LIXT Biotechnology: Pharmaceutical Preparations
- ANGH Telecommunications Equipment
- Sector
- LIXT Health Care
- ANGH Consumer Discretionary
- Exchange
- LIXT Nasdaq
- ANGH Nasdaq
- Market Cap
- LIXT 24.4M
- ANGH 19.7M
- IPO Year
- LIXT N/A
- ANGH N/A
- Fundamental
- Price
- LIXT $4.81
- ANGH N/A
- Analyst Decision
- LIXT
- ANGH
- Analyst Count
- LIXT 0
- ANGH 0
- Target Price
- LIXT N/A
- ANGH N/A
- AVG Volume (30 Days)
- LIXT 155.1K
- ANGH 7.5K
- Earning Date
- LIXT 11-11-2025
- ANGH 10-21-2025
- Dividend Yield
- LIXT N/A
- ANGH N/A
- EPS Growth
- LIXT N/A
- ANGH N/A
- EPS
- LIXT N/A
- ANGH N/A
- Revenue
- LIXT N/A
- ANGH $78,093,405.00
- Revenue This Year
- LIXT N/A
- ANGH N/A
- Revenue Next Year
- LIXT N/A
- ANGH N/A
- P/E Ratio
- LIXT N/A
- ANGH N/A
- Revenue Growth
- LIXT N/A
- ANGH 88.72
- 52 Week Low
- LIXT $0.64
- ANGH $2.53
- 52 Week High
- LIXT $6.26
- ANGH $9.40
- Technical
- Relative Strength Index (RSI)
- LIXT 51.75
- ANGH N/A
- Support Level
- LIXT $4.77
- ANGH N/A
- Resistance Level
- LIXT $5.53
- ANGH N/A
- Average True Range (ATR)
- LIXT 0.47
- ANGH 0.00
- MACD
- LIXT -0.08
- ANGH 0.00
- Stochastic Oscillator
- LIXT 21.66
- ANGH 0.00
About LIXT Lixte Biotechnology Holdings Inc.
Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.
About ANGH Anghami Inc.
Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with a catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner Music. It generates the majority of its revenue from subscriptions.